Richard A. Paulson

CIK: 0001804460

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)12 (60.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (30.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (10.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

KPTI

Karyopharm Therapeutics Inc.

DirectorOfficer

BLUE

bluebird bio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (20 total)

KPTI
Karyopharm Therapeutics Inc.
May 14, 2026
Sale(S)
Direct
2.2K shares at avg. $9.50$21K
KPTI
Karyopharm Therapeutics Inc.
May 13, 2026
Award(A)
Direct
4.9K shares-
KPTI
Karyopharm Therapeutics Inc.
Mar 2, 2026
Sale(S)
Direct
12.4K shares at avg. $9.41$116K
KPTI
Karyopharm Therapeutics Inc.
Feb 5, 2026
Award(A)
Direct
81.1K shares-
KPTI
Karyopharm Therapeutics Inc.
Oct 15, 2025
Award(A)
Direct
114.3K shares-
KPTI
Karyopharm Therapeutics Inc.
Sep 15, 2025
Sale(S)
Direct
1.3K shares at avg. $6.43$8K
KPTI
Karyopharm Therapeutics Inc.
Sep 12, 2025
Award(A)
Direct
2.8K shares-
BLUE
bluebird bio, Inc.
Jun 2, 2025
Disposition(D)
Direct
1.3K shares-
BLUE
bluebird bio, Inc.
May 30, 2025
Tender Offer(U)
Direct
155 shares-
KPTI
Karyopharm Therapeutics Inc.
May 6, 2025
Sale(S)
Direct
236 shares at avg. $7.12$2K
KPTI
Karyopharm Therapeutics Inc.
Apr 4, 2025
Sale(S)
Direct
245 shares at avg. $3.74$916.3
KPTI
Karyopharm Therapeutics Inc.
Mar 4, 2025
Sale(S)
Direct
11.7K shares at avg. $6.29$74K
KPTI
Karyopharm Therapeutics Inc.
Feb 28, 2025
Award(A)
Direct
20K shares-
KPTI
Karyopharm Therapeutics Inc.
Feb 4, 2025
Sale(S)
Direct
4.1K shares at avg. $0.65$3K
KPTI
Karyopharm Therapeutics Inc.
Jan 6, 2025
Sale(S)
Direct
4.1K shares at avg. $0.78$3K
KPTI
Karyopharm Therapeutics Inc.
Dec 4, 2024
Sale(S)
Direct
3.6K shares at avg. $0.81$3K
BLUE
bluebird bio, Inc.
Nov 6, 2024
Award(A)
Direct
24.9K shares-
KPTI
Karyopharm Therapeutics Inc.
Nov 5, 2024
Sale(S)
Direct
3.7K shares at avg. $0.91$3K
KPTI
Karyopharm Therapeutics Inc.
Oct 4, 2024
Sale(S)
Direct
3.6K shares at avg. $0.88$3K
KPTI
Karyopharm Therapeutics Inc.
Sep 4, 2024
Sale(S)
Direct
3.7K shares at avg. $0.72$3K

		Type	Shares	Price		Ownership
May 14, 2026	KPTI Karyopharm Therapeutics Inc.	Sale(S)	2,203	$9.50	$20,929	Direct
May 13, 2026	KPTI Karyopharm Therapeutics Inc.	Award(A)	4,920	-	$0	Direct
Mar 2, 2026	KPTI Karyopharm Therapeutics Inc.	Sale(S)	12,361	$9.41	$116,311	Direct
Feb 5, 2026	KPTI Karyopharm Therapeutics Inc.	Award(A)	81,060	-	$0	Direct
Oct 15, 2025	KPTI Karyopharm Therapeutics Inc.	Award(A)	114,285	-	-	Direct
Sep 15, 2025	KPTI Karyopharm Therapeutics Inc.	Sale(S)	1,257	$6.43	$8,083	Direct
Sep 12, 2025	KPTI Karyopharm Therapeutics Inc.	Award(A)	2,800	-	-	Direct
Jun 2, 2025	BLUE bluebird bio, Inc.	Disposition(D)	1,323	-	-	Direct
May 30, 2025	BLUE bluebird bio, Inc.	Tender Offer(U)	155	-	-	Direct
May 6, 2025	KPTI Karyopharm Therapeutics Inc.	Sale(S)	236	$7.12	$1,680	Direct
Apr 4, 2025	KPTI Karyopharm Therapeutics Inc.	Sale(S)	245	$3.74	$916	Direct
Mar 4, 2025	KPTI Karyopharm Therapeutics Inc.	Sale(S)	11,694	$6.29	$73,555	Direct
Feb 28, 2025	KPTI Karyopharm Therapeutics Inc.	Award(A)	20,000	-	-	Direct
Feb 4, 2025	KPTI Karyopharm Therapeutics Inc.	Sale(S)	4,099	$0.65	$2,664	Direct
Jan 6, 2025	KPTI Karyopharm Therapeutics Inc.	Sale(S)	4,055	$0.78	$3,175	Direct
Dec 4, 2024	KPTI Karyopharm Therapeutics Inc.	Sale(S)	3,620	$0.81	$2,932	Direct
Nov 6, 2024	BLUE bluebird bio, Inc.	Award(A)	24,900	-	$0	Direct
Nov 5, 2024	KPTI Karyopharm Therapeutics Inc.	Sale(S)	3,675	$0.91	$3,346	Direct
Oct 4, 2024	KPTI Karyopharm Therapeutics Inc.	Sale(S)	3,607	$0.88	$3,172	Direct
Sep 4, 2024	KPTI Karyopharm Therapeutics Inc.	Sale(S)	3,667	$0.72	$2,647	Direct

1-20 of 20 transactions

About Paulson Richard A.

Paulson Richard A. (SEC CIK 0001804460) files insider reports with the SEC as President and CEO of Karyopharm Therapeutics Inc. (KPTI) and Director of bluebird bio, Inc. (BLUE).

Signal8 holds 17 ownership filings by Paulson Richard A., all Form 4s, filed between Sep 5, 2024 and May 15, 2026. Those filings report 20 transactions, from Sep 4, 2024 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Paulson Richard A.'s filings is in NEWTON, MA.

Recent filings by Paulson Richard A.

May 14, 2026: Open-market sale of KPTI shares (Form 4, code S).
May 13, 2026: Grant or award of KPTI shares (Form 4, code A).
Mar 2, 2026: Open-market sale of KPTI shares (Form 4, code S).
Feb 5, 2026: Grant or award of KPTI shares (Form 4, code A).
Oct 15, 2025: Grant or award of KPTI shares (Form 4, code A).

Other insiders filing for Karyopharm Therapeutics Inc. (KPTI)

Abate Kristin, Chief Accounting Officer
Poulton Stuart, EVP, Chief Development Officer
Oliger Christy J., Director
PAKIANATHAN DEEPIKA, Director
Schor Chen, Director
Su Zhen, Director

How to read Form 4 transaction codes